Minimal Residual Disease Status as a Surrogate Endpoint for Progression-free Survival in Newly Diagnosed Multiple Myeloma Studies: A Meta-analysis.

21 janvier 2020  | Publications

Avet-Loiseau H, Ludwig H, Landgren O, Paiva B, Morris C, Yang H, Zhou K, Ro S, Mateos MV.

https://www.ncbi.nlm.nih.gov/pubmed/31780415 

---

RETOUR AUX ARTICLES PUBLICATIONS

---